日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints

通过共同靶向核苷酸切除修复和细胞周期检查点来增强合成致死性,从而提高化疗反应

Yi Wen Kong # ,Erik C Dreaden # ,Sandra Morandell ,Wen Zhou ,Sanjeev S Dhara ,Ganapathy Sriram ,Fred C Lam ,Jesse C Patterson ,Mohiuddin Quadir ,Anh Dinh ,Kevin E Shopsowitz ,Shohreh Varmeh ,Ömer H Yilmaz ,Stephen J Lippard ,H Christian Reinhardt ,Michael T Hemann ,Paula T Hammond ,Michael B Yaffe

RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors

RNA 肽纳米复合物药物治疗高级别浆液性卵巢肿瘤中的 DNA 损伤途径

Erik C Dreaden, Yi Wen Kong, Mohiuddin A Quadir, Santiago Correa, Lucia Suárez-López, Antonio E Barberio, Mun Kyung Hwang, Aria C Shi, Benjamin Oberlton, Paige N Gallagher, Kevin E Shopsowitz, Kevin M Elias, Michael B Yaffe, Paula T Hammond

Polymer conjugated retinoids for controlled transdermal delivery

用于控制透皮给药的聚合物结合类视黄酸

Steven A Castleberry, Mohiuddin A Quadir, Malak Abu Sharkh, Kevin E Shopsowitz, Paula T Hammond

Periodic-shRNA molecules are capable of gene silencing, cytotoxicity and innate immune activation in cancer cells

周期性 shRNA 分子能够在癌细胞中沉默基因、产生细胞毒性并激活先天免疫

Kevin E Shopsowitz, Connie Wu, Gina Liu, Erik C Dreaden, Paula T Hammond

Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle

逐层纳米粒子对肿瘤的 MAPK 和 PI3K 进行协同阻断

Erik C Dreaden, Yi Wen Kong, Stephen W Morton, Santiago Correa, Ki Young Choi, Kevin E Shopsowitz, Kasper Renggli, Ronny Drapkin, Michael B Yaffe, Paula T Hammond